¥13.34 ($1.99)

+0.32 (+2.46%)

SHZ · Healthcare · Biotechnology · Tech Score Buy · Power 54 · ¥24.4B mcap · 962M float · 1.30% daily turnover

Revenue

$4.6B +4.5% ▲

5Y CAGR: -1.8%

Gross Profit

$2.5B -3.8% ▼

5Y CAGR: -7.0%

Operating Income

$1.1B -18.1% ▼

5Y CAGR: -12.1%

Net Income

$940M -13.6% ▼

5Y CAGR: -10.2%

EPS (Diluted)

$0.52 -11.9% ▼

5Y CAGR: -10.2%

EBITDA

$1.4B -1.9% ▼

5Y CAGR: -8.3%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$4.4B	$4.5B	$5.3B	$4.4B	$4.6B
YoY Growth	-11.7%	+1.8%	+18.3%	-18.0%	+4.5%
Cost of Revenue	$1.5B	$1.7B	$1.7B	$1.8B	$2.1B
Gross Profit	$2.9B	$2.8B	$3.6B	$2.6B	$2.5B
Gross Margin	65.3%	62.4%	67.7%	59.6%	54.9%
R&D Expenses	$254M	$315M	$281M	$333M	$296M
SG&A Expenses	$1.0B	$1.2B	$1.5B	$1.1B	$1.0B
Operating Expenses	$1.2B	$1.4B	$1.5B	$1.2B	$1.4B
Operating Income	$1.7B	$1.4B	$2.1B	$1.4B	$1.1B
Operating Margin	38.2%	31.5%	39.3%	31.5%	24.7%
Interest Expense	$22M	$31M	$13M	$13M	$11M
Income Before Tax	$1.7B	$1.4B	$2.1B	$1.3B	$1.2B
Tax Expense	$234M	$181M	$316M	$183M	$173M
Net Income	$1.3B	$1.1B	$1.5B	$1.1B	$940M
Net Margin	29.3%	23.8%	27.7%	24.8%	20.6%
EPS (Diluted)	$0.71	$0.59	$0.81	$0.59	$0.52
EBITDA	$1.8B	$1.5B	$2.1B	$1.4B	$1.4B
Shares Outstanding	1.83B	1.83B	1.82B	1.83B	1.83B

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.8B	$889M	$868M	$931M	$1.6B	$1.2B	$762M	$805M
Cost of Revenue	$513M	$434M	$379M	$463M	$577M	$550M	$380M	$491M
Gross Profit	$1.3B	$455M	$488M	$468M	$1.0B	$666M	$382M	$314M
Gross Margin	72.1%	51.2%	56.3%	50.3%	63.5%	54.8%	50.2%	39.0%
R&D Expenses	$67M	$121M	$66M	$95M	$73M	$93M	$60M	$55M
SG&A Expenses	$584M	$201M	$99M	$176M	$563M	$253M	$94M	$142M
Operating Expenses	$642M	$297M	$91M	$230M	$648M	$428M	$164M	$197M
Operating Income	$683M	$158M	$397M	$238M	$356M	$238M	$219M	$117M
Operating Margin	37.2%	17.7%	45.8%	25.5%	22.5%	19.6%	28.7%	14.5%
Interest Expense	$3M	$2M	$3M	$3M	$893K	$4M	$96K	$96K
Income Before Tax	$665M	$140M	$385M	$227M	$361M	$201M	$290M	$184M
Tax Expense	$102M	-$4M	$61M	$28M	$56M	$29M	$47M	$32M
Net Income	$483M	$164M	$313M	$203M	$269M	$156M	$230M	$153M
Net Margin	26.3%	18.5%	36.1%	21.8%	17.0%	12.8%	30.2%	19.0%
EPS (Diluted)	$0.26	$0.09	$0.17	$0.11	$0.15	$0.09	$0.13	$0.08
EBITDA	$692M	$186M	$412M	$257M	$387M	$276M	$290M	$187M
Shares Outstanding	1.83B	1.83B	1.83B	1.83B	1.83B	1.83B	1.83B	1.83B

002007.SZ SHZ